Cargando…

同时性多原发肺癌的预后及生存相关因素研究

BACKGROUND AND OBJECTIVE: Synchronous multiple primary lung cancer (sMPLC) is a sparse disease in the past, but there has been a gradual increase in the morbidity of sMPLC recently. However, studies on large sample have never been undertaken. The purpose of this study is to investigate the diagnosis...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973290/
https://www.ncbi.nlm.nih.gov/pubmed/28103969
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.03
_version_ 1783326585608208384
collection PubMed
description BACKGROUND AND OBJECTIVE: Synchronous multiple primary lung cancer (sMPLC) is a sparse disease in the past, but there has been a gradual increase in the morbidity of sMPLC recently. However, studies on large sample have never been undertaken. The purpose of this study is to investigate the diagnosis, treatment and prognosis of sMPLC through analyzing the clinical data, and provide supports for the management of sMPLC. METHODS: According to Martini-Melamed criteria, 357 patients were diagnosed sMPLC. The pathological staging is on the basis of the 8(th) edition tumor-node-metastasis (TNM) staging from International Association for the Study of Lung Cancer (IASLC). RESULTS: There were 269 patients with double primary lung cancer, 65 patients with triple primary lung cancer and 23 patients with four or more primary lung cancer. Lesions (68.55%, 571/833) were frequently in upper lobe, especially the right upper lobe. Adenocarcinoma (95.56%, 796/833) was the mainly pathological type, followed by squamous cell carcinoma (2.40%, 20/833). The acinar predominant subtype was the main part (70.81%, 313/442) of the all adenocarcinoma specimens. Most of the lesions (68.35%, 244/357) were stage Ib or low. Among the initial lesion and the following lesions, patients who had the same pathological type (92.72%, 331/357) were more than the different (7.28%, 26/357), of which adenocarcinoma-adenocarcinoma occupied the major proportion (99.40%, 329/331). The 3-year overall survival (OS) and 5-year overall survival were respective 91.93% and 84.37%. Multivariate analysis found that smoking history (P=0.012), the diameter of the maximum lesion (P=0.027), lymph node metastasis (P=0.015) and pleural invasion (P < 0.001) were the independent risk factors for prognosis. CONCLUSION: Tumours in patients with sMPLC are more frequently in the right upper lobe. Adenocarcinoma was the mainly pathological type. Smoking history, the diameter of the maximum lesion, lymph node metastasis and pleural invasion were the independent risk factors for prognosis. Early diagnosis and active operation can obtain better prognosis.
format Online
Article
Text
id pubmed-5973290
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59732902018-07-06 同时性多原发肺癌的预后及生存相关因素研究 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Synchronous multiple primary lung cancer (sMPLC) is a sparse disease in the past, but there has been a gradual increase in the morbidity of sMPLC recently. However, studies on large sample have never been undertaken. The purpose of this study is to investigate the diagnosis, treatment and prognosis of sMPLC through analyzing the clinical data, and provide supports for the management of sMPLC. METHODS: According to Martini-Melamed criteria, 357 patients were diagnosed sMPLC. The pathological staging is on the basis of the 8(th) edition tumor-node-metastasis (TNM) staging from International Association for the Study of Lung Cancer (IASLC). RESULTS: There were 269 patients with double primary lung cancer, 65 patients with triple primary lung cancer and 23 patients with four or more primary lung cancer. Lesions (68.55%, 571/833) were frequently in upper lobe, especially the right upper lobe. Adenocarcinoma (95.56%, 796/833) was the mainly pathological type, followed by squamous cell carcinoma (2.40%, 20/833). The acinar predominant subtype was the main part (70.81%, 313/442) of the all adenocarcinoma specimens. Most of the lesions (68.35%, 244/357) were stage Ib or low. Among the initial lesion and the following lesions, patients who had the same pathological type (92.72%, 331/357) were more than the different (7.28%, 26/357), of which adenocarcinoma-adenocarcinoma occupied the major proportion (99.40%, 329/331). The 3-year overall survival (OS) and 5-year overall survival were respective 91.93% and 84.37%. Multivariate analysis found that smoking history (P=0.012), the diameter of the maximum lesion (P=0.027), lymph node metastasis (P=0.015) and pleural invasion (P < 0.001) were the independent risk factors for prognosis. CONCLUSION: Tumours in patients with sMPLC are more frequently in the right upper lobe. Adenocarcinoma was the mainly pathological type. Smoking history, the diameter of the maximum lesion, lymph node metastasis and pleural invasion were the independent risk factors for prognosis. Early diagnosis and active operation can obtain better prognosis. 中国肺癌杂志编辑部 2017-01-20 /pmc/articles/PMC5973290/ /pubmed/28103969 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.03 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
同时性多原发肺癌的预后及生存相关因素研究
title 同时性多原发肺癌的预后及生存相关因素研究
title_full 同时性多原发肺癌的预后及生存相关因素研究
title_fullStr 同时性多原发肺癌的预后及生存相关因素研究
title_full_unstemmed 同时性多原发肺癌的预后及生存相关因素研究
title_short 同时性多原发肺癌的预后及生存相关因素研究
title_sort 同时性多原发肺癌的预后及生存相关因素研究
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973290/
https://www.ncbi.nlm.nih.gov/pubmed/28103969
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.01.03
work_keys_str_mv AT tóngshíxìngduōyuánfāfèiáideyùhòujíshēngcúnxiāngguānyīnsùyánjiū
AT tóngshíxìngduōyuánfāfèiáideyùhòujíshēngcúnxiāngguānyīnsùyánjiū
AT tóngshíxìngduōyuánfāfèiáideyùhòujíshēngcúnxiāngguānyīnsùyánjiū
AT tóngshíxìngduōyuánfāfèiáideyùhòujíshēngcúnxiāngguānyīnsùyánjiū
AT tóngshíxìngduōyuánfāfèiáideyùhòujíshēngcúnxiāngguānyīnsùyánjiū